Steve Slilaty
Chief Executive Officer at SUNSHINE BIOPHARMA, INC.
Net worth: 15 061 $ as of 2024-03-30
Profile
Steve N.
Slilaty is the founder of MP Biomedicals Canada ULC, founded in 1991.
He is also the founder of Advanomics Corp., founded in 2002, where he holds the title of President & Chief Scientific Officer.
Dr. Slilaty's current job positions include Chairman, President & Chief Executive Officer at Sunshine Biopharma, Inc. since 2009, Director at Nora Pharma, Inc., and Adjunct Professor at the University of Quebec since 2011.
Dr. Slilaty's former job positions include Chairman, President & Chief Executive Officer at Mountain West Business Solutions, Inc. in 2009 and Chairman, President & Chief Executive Officer at Sunshine Biopharma, Inc. in 2009.
Dr. Slilaty's education history includes an undergraduate degree from Cornell University in 1976 and a doctorate degree from the University of Arizona in 1983.
Dr. Slilaty is also the founder of ALERT B&C Corp...
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-03 | 130,000 ( 13.00% ) | 7 800 $ | 2024-03-30 | |
2024-02-12 | 121,024 ( 0.12% ) | 7 261 $ | 2024-03-30 |
Steve Slilaty active positions
Companies | Position | Start |
---|---|---|
SUNSHINE BIOPHARMA, INC. | Chief Executive Officer | 2009-10-14 |
Advanomics Corp.
Advanomics Corp. BiotechnologyHealth Technology Advanomics Corp. is a Canadian company that focuses on researching and developing treatments for cancer and other human diseases. The private company is based in Montréal, Canada. and has subsidiaries in Canada. The company was founded by Steve N. Slilaty and Camille Sebaaly. | Founder | 2009-11-26 |
University of Quebec | Corporate Officer/Principal | 2010-09-26 |
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Director/Board Member | - |
Former positions of Steve Slilaty
Companies | Position | End |
---|---|---|
Sunshine Biopharma, Inc. /Old/ | Chairman | 2009-11-24 |
Mountain West Business Solutions, Inc. | Chairman | 2009-11-24 |
ALERT B&C Corp.
ALERT B&C Corp. Miscellaneous Commercial ServicesCommercial Services ALERT B&C Corp. is a biodefence company, which develops healthcare solutions for genomic manipulations and gene discovery. It also supplies the biodefence market with quality technologies, products and solutions, in order to improve and maintain the safety and the security of individuals worldwide. The products offered by the corporation are detection and identification equipment, such as the TRAKER, and ionization sources, designed for the identification of dangerous and toxic biological and chemical agents. The company was founded on October 6, 1995 and is headquartered in Calgary, Canada. | Founder | - |
MP Biomedicals Canada ULC
MP Biomedicals Canada ULC Miscellaneous Commercial ServicesCommercial Services MP Bio medicals Canada Ulc provides genomics and gene delivery research tools and services. The firm’s products include PCR, transfection, protemics, lab tools and instruments, and enzyme products. It has operations in Canada, France, Switzerland and the United States. The company was founded in 1991 and is headquartered in Montréal, Canada. | Founder | - |
Training of Steve Slilaty
Cornell University | Undergraduate Degree |
University of Arizona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SUNSHINE BIOPHARMA, INC. | Health Technology |
Private companies | 6 |
---|---|
ALERT B&C Corp.
ALERT B&C Corp. Miscellaneous Commercial ServicesCommercial Services ALERT B&C Corp. is a biodefence company, which develops healthcare solutions for genomic manipulations and gene discovery. It also supplies the biodefence market with quality technologies, products and solutions, in order to improve and maintain the safety and the security of individuals worldwide. The products offered by the corporation are detection and identification equipment, such as the TRAKER, and ionization sources, designed for the identification of dangerous and toxic biological and chemical agents. The company was founded on October 6, 1995 and is headquartered in Calgary, Canada. | Commercial Services |
MP Biomedicals Canada ULC
MP Biomedicals Canada ULC Miscellaneous Commercial ServicesCommercial Services MP Bio medicals Canada Ulc provides genomics and gene delivery research tools and services. The firm’s products include PCR, transfection, protemics, lab tools and instruments, and enzyme products. It has operations in Canada, France, Switzerland and the United States. The company was founded in 1991 and is headquartered in Montréal, Canada. | Commercial Services |
Mountain West Business Solutions, Inc. | Commercial Services |
Sunshine Biopharma, Inc. /Old/ | Commercial Services |
Advanomics Corp.
Advanomics Corp. BiotechnologyHealth Technology Advanomics Corp. is a Canadian company that focuses on researching and developing treatments for cancer and other human diseases. The private company is based in Montréal, Canada. and has subsidiaries in Canada. The company was founded by Steve N. Slilaty and Camille Sebaaly. | Health Technology |
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Distribution Services |
- Stock Market
- Insiders
- Steve Slilaty